DelMar Pharmaceuticals Inc Stock Nasdaq
Equities
US2470782077
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.82M |
---|---|---|---|---|---|
Net income 2022 | -22M | Net income 2023 | -14M | EV / Sales 2022 | - |
Net cash position 2022 | 11.78M | Net cash position 2023 | 2.61M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.54
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.81% |
Latest transcript on DelMar Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 18-04-10 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 18-04-10 |
Tamara Favorito
BRD | Director/Board Member | 65 | 21-04-28 |
Laura Douglass
BRD | Director/Board Member | 59 | 20-06-25 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.55% | 22.02B | |
-17.84% | 20.9B | |
-9.00% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |